Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1714.63 (Glytoucan)

Id:4fea77b8-2673-5774-85cb-4b472227b2ee

Glytoucan:G89797AN

Results found

Linked to

	Label	Description
	1714.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G77791EJ-GLYCOSEQ00161175 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1714.63 has canonical residue n-glycan b-d-glcpnac 5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1714.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G62037CU-GLYCOSEQ00168530 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1714.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G09615HM-GLYCOSEQ00040045 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1714.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G34822AT-GLYCOSEQ00098193 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1714.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G62037CU-GLYCOSEQ00168529 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1714.63 has canonical residue n-glycan b-d-glcpnac 2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1714.63 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000001 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1714.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G59454IE-GLYCOSEQ00146463 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1714.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G70457JV-GLYCOSEQ00049813 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1714.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G77791EJ-GLYCOSEQ00161175 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1714.63 has canonical residue n-glycan b-d-glcpnac 5

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1714.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G62037CU-GLYCOSEQ00168530 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1714.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G09615HM-GLYCOSEQ00040045 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1714.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G34822AT-GLYCOSEQ00098193 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1714.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G62037CU-GLYCOSEQ00168529 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1714.63 has canonical residue n-glycan b-d-glcpnac 2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1714.63 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000001 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1714.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G59454IE-GLYCOSEQ00146463 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1714.63 has glycosequence GLYGEN.GLYCOSEQUENCE:G70457JV-GLYCOSEQ00049813 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.